Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 2 $ 156,017 $ (108,484) $ 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs [2] [1] 37 37
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs (in Shares) [2] 27,171      
Stock-based compensation expenses 615 615
Net loss (8,169) (8,169)
Balance at Mar. 31, 2022 $ 2 156,669 (116,653) 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
Balance at Dec. 31, 2021 $ 2 156,017 (108,484) 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Net loss       (22,431)
Balance at Sep. 30, 2022 $ 2 157,471 (130,915) 26,558
Balance (in Shares) at Sep. 30, 2022 29,976,582      
Balance at Mar. 31, 2022 $ 2 156,669 (116,653) 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
Stock-based compensation expenses 184 184
Proceeds on account of shares 19 19
Net loss (7,482) (7,482)
Balance at Jun. 30, 2022 $ 2 156,872 (124,135) 32,739
Balance (in Shares) at Jun. 30, 2022 29,774,709      
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs [2] [1] 236   236
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs (in Shares) [2] 201,873      
Stock-based compensation expenses 363 363
Net loss     (6,780) (6,780)
Balance at Sep. 30, 2022 $ 2 157,471 (130,915) 26,558
Balance (in Shares) at Sep. 30, 2022 29,976,582      
Balance at Dec. 31, 2022 $ 2 157,838 (136,801) $ 21,039
Balance (in Shares) at Dec. 31, 2022 29,976,582     29,976,582
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs [2] [1] 1,293 $ 1,293
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs (in Shares) [2] 3,199,491      
Stock-based compensation expenses 175 175
Net loss (6,361) (6,361)
Balance at Mar. 31, 2023 $ 2 159,306 (143,162) 16,146
Balance (in Shares) at Mar. 31, 2023 33,176,073      
Balance at Dec. 31, 2022 $ 2 157,838 (136,801) $ 21,039
Balance (in Shares) at Dec. 31, 2022 29,976,582     29,976,582
Net loss       $ (20,678)
Balance at Sep. 30, 2023 $ 3 165,630 (157,479) $ 8,154
Balance (in Shares) at Sep. 30, 2023 45,974,030     45,974,030
Balance at Mar. 31, 2023 $ 2 159,306 (143,162) $ 16,146
Balance (in Shares) at Mar. 31, 2023 33,176,073      
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs [2] $ 1 5,858   5,859
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs (in Shares) [2] 12,797,957      
Stock-based compensation expenses 271   271
Net loss     (6,411) (6,411)
Balance at Jun. 30, 2023 $ 3 165,435 (149,573) 15,865
Balance (in Shares) at Jun. 30, 2023 45,974,030      
Stock-based compensation expenses   195 195
Net loss   (7,906) (7,906)
Balance at Sep. 30, 2023 $ 3 $ 165,630 $ (157,479) $ 8,154
Balance (in Shares) at Sep. 30, 2023 45,974,030     45,974,030
[1] Less than $1.
[2] See Note 8A.